Professional Documents
Culture Documents
(CHAPTER 185)
PART I
PRELIMINARY
Section
1. Short title
2. Interpretation
3. Appointment of Director and other officers of Central Narcotics
Bureau
4. Advisory committees
PART II
OFFENCES INVOLVING CONTROLLED DRUGS AND SUBSTANCES
5. Trafficking in controlled drugs
6. Manufacture of controlled drugs
7. Import and export of controlled drugs
8. Possession and consumption of controlled drugs
8A. Consumption of drug outside Singapore by citizen or permanent
resident
9. Possession of pipes, utensils, etc.
10. Cultivation of cannabis, opium and coca plants
10A. Manufacture, supply, possession, import or export of equipment,
materials or substances useful for manufacture of controlled
drugs
10B. Regulations on controlled equipment, material or substances
11. Responsibilities of owners, tenants, etc.
11A. Arranging or planning gatherings where controlled drugs are to
be consumed or trafficked
12. Abetments and attempts punishable as offences
12A. Causing or procuring young person or vulnerable person to
commit certain offences
13. Abetting or procuring commission of offences outside Singapore
14. Offences by body corporate
PART IV
TREATMENT AND REHABILITATION
34. Supervision, treatment and rehabilitation of drug addicts
35. Approved institutions and community rehabilitation centres
36. Administration of approved institutions
36A. Administration of community rehabilitation centres
37. Review Committees for approved institutions and community
rehabilitation centres
38. Review, discharge and transfer of inmates
Section
39. Power of Magistrate to inquire into complaint of misconduct or
breach of duty
40. Inmates deemed to be in legal custody
PART V
TAKING OF PHOTOGRAPHS, FINGER IMPRESSIONS, PARTICULARS
AND BODY SAMPLES
40A. Interpretation of this Part
40B. Taking of photographs, finger impressions, particulars and body
samples from person subject to supervision or in approved
institutions
40C. Further provisions for taking of body samples
40D. Retention of photographs, finger impressions, particulars and
body samples taken
PART VI
COMMITTEE OF INQUIRY
41. Committee of inquiry
42. Composition of committee of inquiry
43. Powers of committee of inquiry
44. Disobedience to summons
45. Refusal to give evidence
46. Giving of false evidence
47. Evidence and procedure
48. Admissibility of evidence
49. Proceedings not open to public
50. Persons who may be affected by findings
51. Record of proceedings
52. Offence to influence or attempt to influence committee of
inquiry
PART VII
GENERAL
53. Jurisdiction of court
54. Indemnity
55. Protection of persons acting under authority of Act
56. Use of weapons
57. Employment of auxiliary police officers as escorts and guards
PART I
PRELIMINARY
Short title
1. This Act may be cited as the Misuse of Drugs Act.
Interpretation
2. In this Act, unless the context otherwise requires —
“approved institution” means any institution or place declared
by the Minister to be an approved institution under
section 35;
“article liable to seizure” means any money, thing, controlled
equipment or controlled material by means of or in respect of
which an offence under this Act has been committed or which
contains evidence of an offence under this Act;
“cannabis” means any part of a plant of the genus Cannabis, or
any part of such plant, by whatever name it is called;
“manufacture”, in relation to —
(a) a controlled drug, includes any process of producing
the drug and the refining or transformation of one
drug into another; or
(b) a controlled substance, includes any process of
producing the substance and the refining or
transformation of one substance into another;
“officer of customs” has the same meaning as in the Customs
Act (Cap. 70);
“police officer” has the same meaning as in the Police Force Act
(Cap. 235);
“prison officer” has the same meaning as in the Prisons Act
(Cap. 247);
“regulations” means any regulations made under this Act;
“Review Committee”, in relation to an approved institution,
means the Review Committee appointed for the institution
under section 37;
(3) Subject to the provisions of this Act, the powers and functions
conferred upon the Director under this Act, and the duties required to
be discharged by him may, subject to such limitations as the Director
may impose, be exercised and discharged by any Deputy Director or
Divisional Director of the Central Narcotics Bureau duly authorised
by the Director to act on his behalf.
[Act 30 of 2012 wef 01/01/2013]
(4) The Director may issue such orders not inconsistent with the
provisions of this Act and the regulations made thereunder, to be
called General Orders, as he may think necessary and expedient for
the control, direction and information of the officers of the Bureau.
[Act 30 of 2012 wef 01/01/2013]
Advisory committees
4.—(1) For the purpose of assisting in the administration of this
Act, the Minister may from time to time appoint such advisory
committees as he thinks fit.
[12/77]
(2) Every such committee shall have such functions as the Minister
may from time to time determine.
[12/77]
(4) Regulations made under this section may provide that any
person who contravenes any provision thereof shall be guilty of an
offence and shall be liable on conviction to be punished with a fine
not exceeding $10,000 or with imprisonment for a term not exceeding
3 years or with both as may be specified in the regulations.
[20/98]
Protection of informers
23.—(1) Except as provided in subsection (3) —
(a) no information for an offence under this Act shall be
admitted in evidence in any civil or criminal proceedings;
and
(b) no witness in any civil or criminal proceedings shall be
obliged —
(i) to disclose the name and address of any informer
who has given information with respect to an offence
under this Act; or
(ii) to answer any question if the answer thereto would
lead, or would tend to lead, to the discovery of the
name or address of the informer.
(2) If any book, document or paper which is in evidence or liable to
inspection in any civil or criminal proceedings contains any entry in
which any informer is named or described or which may lead to his
discovery, the court shall cause those entries to be concealed from
view or to be obliterated so far as may be necessary to protect the
informer from discovery.
(3) If —
(a) in any proceedings before a court for an offence under this
Act, the court, after full inquiry into the case, is satisfied
that an informer wilfully made a material statement which
he knew or believed to be false or did not believe to be true;
or
(b) in any other proceedings, the court is of the opinion that
justice cannot be fully done between the parties thereto
without the disclosure of the name of an informer,
(2) For the purpose of exercising his power under this section, an
officer may, with such assistance as he considers necessary, break
open any door, window, lock, fastener, floor, wall, ceiling,
compartment, box, container or any other thing.
(3) Notwithstanding subsection (1), if the use of any drug specified
in the Fifth Schedule or any substance containing such drug at any
place or premises searched under that subsection is authorised by the
Director, that drug or substance shall not be liable to seizure under
that subsection.
[Act 30 of 2012 wef 01/05/2013]
Powers of arrest
25.—(1) Any officer of the Bureau, police officer, officer of
customs, or special police officer or member of the Vigilante Corps
authorised in writing by a police officer not below the rank of
Assistant Superintendent of Police, may arrest and search without a
warrant any person who has committed or whom he reasonably
suspects to have committed an offence under this Act or a seizable
offence under the regulations.
[12/77; 20/98]
(2) Any person arrested under subsection (1) shall, together with
any controlled drug, controlled substance or article liable to seizure,
be taken to the Central Narcotics Bureau, a police station or a customs
station and may be searched.
[49/75; 20/98]
one month from the date of the seizure thereof unless a claim thereto
has been made before that date in such manner as may be prescribed.
[20/98]
(2) Where a person has been convicted of an offence under this Act,
the court shall, upon the application of the Public Prosecutor, order to
be forfeited to the Government any vehicle which has been proved to
have been used in any manner in connection with the offence.
[20/98]
(3) This section shall not apply to any ship or hovercraft of more
than 200 tons net or to any aircraft belonging to any person carrying
on a regular passenger service to and from Singapore by means of that
aircraft.
(4) No ship, hovercraft, aircraft or vehicle shall be forfeited under
this section if it is established by the owner thereof that the ship,
hovercraft, aircraft or vehicle was unlawfully in the possession of
another person without the consent of the owner.
Urine tests
31.—(1) Any officer of the Bureau, immigration officer or police
officer not below the rank of sergeant may, if he reasonably suspects
any person to have committed an offence under section 8(b), require
that person to provide a specimen of his urine for urine tests to be
conducted under this section.
[12/77; 38/89]
(7) The certificate stating the result of a urine test may be signed by
an analyst or person appointed under subsection (6) notwithstanding
that he did not personally conduct the test to analyse the urine
specimen as long as the test was conducted by another person acting
under his direction.
[Act 30 of 2012 wef 01/05/2013]
Hair tests
31A.—(1) Any officer of the Bureau, immigration officer or police
officer not below the rank of sergeant may, if he reasonably suspects
any person to have committed an offence under section 8(b), require
that person to provide specimens of his hair for a hair test to be
conducted under this section.
(2) A person who fails, without reasonable excuse, to provide
specimens of his hair of such type and quantity as may be required by
any of the officers referred to in subsection (1) shall be guilty of an
offence.
(3) All specimens of hair provided under this section shall be
marked and sealed for hair testing in accordance with the prescribed
procedure.
(4) A certificate stating the result of a hair test shall be signed by an
analyst employed by the Health Sciences Authority or any other
person that the Minister, by notification in the Gazette, appoints for
such purpose.
(5) The certificate stating the result of a hair test may be signed by
an analyst or person appointed under subsection (4) notwithstanding
that he did not personally conduct the test to analyse the specimens of
hair as long as the test was conducted by another person acting under
his direction.
[Act 30 of 2012 wef 01/05/2013]
(3) For the purposes of subsections (1) and (2)(a), when an officer
of the Bureau is exercising the powers of a police officer under the
Criminal Procedure Code 2010, the officer of the Bureau shall be
deemed to be an officer not below the rank of inspector of police.
[15/2010 wef 02/01/2011]
(4A) Where —
(a) any person is convicted of an offence under section 5(1) or
7; and
(b) that person is again convicted of an offence under
section 5(1) or 7,
that person so convicted shall be punished with —
(i) in relation to a Class A drug —
(A) imprisonment for a term of not less than 10 years and
not more than 30 years; and
(B) not less than 10 strokes and not more than 15 strokes
of the cane;
(ii) in relation to a Class B drug —
(A) imprisonment for a term of not less than 6 years and
not more than 30 years; and
(B) not less than 6 strokes and not more than 15 strokes
of the cane; and
(iii) in relation to a Class C drug —
(A) imprisonment for a term of not less than 4 years and
not more than 20 years; and
(B) not less than 4 strokes and not more than 15 strokes
of the cane.
[Act 30 of 2012 wef 01/05/2013]
(2) Where a person who has been punished under subsection (1) is
again convicted of an offence for consumption of a specified drug
under section 8(b) or an offence of failure to provide a urine specimen
under section 31(2), he shall on conviction be punished with —
(a) imprisonment of not less than 7 years and not more than 13
years; and
PART IV
TREATMENT AND REHABILITATION
Supervision, treatment and rehabilitation of drug addicts
34.—(1) The Director may require any person whom he reasonably
suspects to be a drug addict to be medically examined or observed by
a Government medical officer or a medical practitioner.
[38/89]
(4) If, after considering the result of any such inquiry, the
Magistrate is satisfied that any person who is detained in an
approved institution or a community rehabilitation centre ought not
to be so detained, the Magistrate may make an order for the discharge
of that person from the approved institution or community
rehabilitation centre and that person shall be discharged accordingly.
[Act 30 of 2012 wef 28/04/2014]
(5) Any order or decision of the Magistrate made under this section
shall be final.
[12/77]
(6) No evidence taken for the purpose of any such inquiry shall be
admissible in any civil or criminal proceedings, except where the
person who gave that evidence is charged with giving or fabricating
false evidence.
[12/77]
(5) No —
(a) sample of blood; or
(b) intimate sample prescribed under section 40A(2),
shall be taken from any person unless the appropriate consent is given
for the taking of the sample.
[2/2006]
(2) Before taking any body sample, the person authorised under
subsection (1) to take the sample must satisfy himself that the taking
of the sample does not endanger the person from whom the sample is
to be taken.
[2/2006]
(3) The fact that a body sample has been taken shall be recorded by
the person who took the sample in such form or manner as may be
required by the Commissioner of Police.
[2/2006]
(2) Any information stored in the register and the DNA database
under subsection (1) may be used for all or any of the following
purposes:
(a) for comparison with any other information or any other
DNA information, as the case may be, obtained in the
course of an investigation of an offence conducted by a
police officer or an officer of the Bureau;
(b) for comparison with information in the register established
under section 4 of the Registration of Criminals Act
(Cap. 268) or with DNA information in the DNA database
established under section 13F of that Act, as the case may
be;
(c) for comparison with information or DNA information, as
the case may be, in the register or DNA database,
respectively, established under —
(i) section 27C of the Criminal Law (Temporary
Provisions) Act (Cap. 67); or
(ii) section 26D of the Intoxicating Substances Act
(Cap. 146A);
PART VI
COMMITTEE OF INQUIRY
Committee of inquiry
41.—(1) Where it is expedient that the Minister, or such other
person as the Minister may appoint to exercise the powers conferred
upon the Minister by sections 42, 49 and 51, should be informed on
any matter connected with the discipline, administration or functions
of any approved institution or affecting any inmate, the Minister or
the person appointed by the Minister may convene a committee of
inquiry.
[8/2000]
(2) A committee of inquiry shall inquire into and report on the facts
relating to any matter referred to it and, if directed by the Minister to
(3) In this section and in sections 42, 49 and 51, “Minister” includes
the person appointed by the Minister under subsection (1) to act on
his behalf for the purposes of this section and sections 42, 49 and 51.
[8/2000]
Disobedience to summons
44.—(1) A person who is summoned to give evidence before a
committee of inquiry shall not, without lawful excuse, fail to appear
in obedience to the summons.
[8/2000]
Record of proceedings
51.—(1) The chairman shall record or cause to be recorded in
writing the proceedings of the committee of inquiry.
[8/2000]
PART VII
GENERAL
Jurisdiction of court
53. A District Court or a Magistrate’s Court shall have jurisdiction
to hear and determine all proceedings under this Act and,
notwithstanding anything to the contrary in the Criminal Procedure
Code (Cap. 68), a District Court shall have power to impose the full
penalty or punishment in respect of any offence provided by this Act
except the punishment of death.
[49/75]
Indemnity
54.—(1) The Government shall not be liable to make good any
damage caused to any goods or property as a result of an entry, search
or detention under the provisions of this Act unless the damage is
caused by the wilful neglect or default of an officer employed by the
Government.
Use of weapons
56.—(1) Subject to this section, a prison officer may use any
weapon against —
(a) any inmate of any approved institution escaping or
attempting to escape;
(b) any person who does any act or attempts to do any act to
facilitate the escape of an inmate of any approved
institution; or
(c) any person engaged in any attempt to damage or force or
break open —
(i) the outside door or gate or enclosure wall of any
approved institution or any other part of an approved
institution; or
(ii) any part of any vehicle in which an inmate is
conveyed.
[8/2000]
(3) Every prison officer may use weapons against an inmate of any
approved institution using violence against any prison officer or other
person, if the prison officer has reasonable ground to believe that the
prison officer or other person is in danger of life or limb, or that other
grievous hurt is likely to be caused to either of them.
[8/2000]
(4) A prison officer shall not resort to the use of any weapon under
subsection (1) unless the officer has reasonable ground to believe that
he cannot otherwise prevent the escape of any inmate.
[8/2000]
(7) The use of weapons under this section shall be, as far as
possible, to disable and not to kill.
[8/2000]
(8) Every police officer who is for the time being serving in the
capacity of an escort, or of a guard in or around any approved
institution, for the purpose of ensuring the safe custody of any inmate,
shall be deemed to have all the powers and privileges granted to a
prison officer under this section.
[8/2000]
(5) For the purpose of this section, “auxiliary police officer” means
a member of an auxiliary police force established under any other
written law.
[8/2000; 3/2005]
Regulations
58.—(1) The Minister may make regulations —
(a) providing for the issue of licences for the import, export,
sale, manufacture, production or distribution of controlled
drugs;
(b) prescribing the form, duration and terms and conditions of
any licence and the fees payable therefor, and providing for
the cancellation and suspension thereof;
(c) authorising the sale or possession or other dealing in
controlled drugs and prescribing the circumstances and
CONTROLLED DRUGS
PART I
CLASS A DRUGS
1. The following substances and products:
(1) Acetorphine
(2) Acetylmethadol
(3) Allylprodine
(4) Alphacetylmethadol
(5) Alphameprodine
(6) Alphamethadol
(7) Alphaprodine
(8) [Deleted by S 194/2017 wef 01/05/2017]
(9) Amphetamine
(10) Anileridine
(11) Benzethidine
(12) Benzylmorphine (3-benzylmorphine)
(13) 1-Benzylpiperazine (also known as BZP)
(14) Betacetylmethadol
(15) Betameprodine
(16) Betamethadol
(17) Betaprodine
(18) Bezitramide
(19) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine (also known as
Brolamfetamine or DOB)
(20) 2-(4-Bromo-2,5-dimethoxyphenyl)ethanamine (also known as 4-
bromo-2,5-dimethoxyphenethylamine or 2C-B) and its bromo and
dimethoxy positional isomers in the phenyl ring
[S 194/2017 wef 01/05/2017]
(134) Tenocyclidine
(134A) 6,7,8,14-Tetradehydro-4,5-α-epoxy-6-methoxy-17-methylmorphinan-
3-ol (also known as 3-O-demethylthebaine or Oripavine)
[S 233/2018 wef 01/05/2018]
(135) Thebacon
(136) Thebaine
(137) Tilidine
(138) 1-(3-Trifluoromethylphenyl)piperazine (also known as TFMPP)
(139) Trimeperidine
(140) 3,4,5-Trimethoxy-α-methylphenethylamine
2. Any stereoisomeric form of a substance for the time being specified in
paragraph 1, not being dextromethorphan or dextrorphan.
3. Any ester or ether of a substance for the time being specified in paragraph 1 or
2, not being a substance for the time being specified in Part II.
4. Any salt of a substance for the time being specified in any of paragraphs 1, 2
and 3.
5. Any preparation or other products containing a substance or product for the
time being specified in any of paragraphs 1 to 4.
6. Any preparation designed for administration by injection which includes a
substance or product for the time being specified in any of paragraphs 1, 2 and 3 of
Part II.
(1A) Alfentanil
[S 200/2016 wef 01/05/2016]
(8) Carfentanil
(8A) 4-Fluoroisobutyrfentanyl (also known as 4-FIBF or pFIBF)
[S 233/2018 wef 01/05/2018]
(9) Lofentanil
(10) 3-Methyl fentanyl
(10A) 3-Methylthiofentanyl
[S 233/2018 wef 01/05/2018]
(10B) Ocfentanil
[S 233/2018 wef 01/05/2018]
(11) Para-fluorofentanyl
(11A) Remifentanil
[S 233/2018 wef 01/05/2018]
(12) Sufentanil
(12AA) Tetrahydrofuranyl fentanyl (also known as THF-F)
[S 233/2018 wef 01/05/2018]
(13) Thiofentanyl
8. Any compound containing a 3-(1-naphthoyl)indole structure with substitution
at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-
morpholinyl)ethyl group, and any derivatives of the above compounds containing
hydroxy and/or carboxylic acid groups, whether or not further substituted in the
indole ring to any extent and whether or not substituted in the naphthyl ring to any
extent, including any salt or stereoisomeric form of the above compounds or
derivatives, and any preparation or product containing the above compounds or
derivatives, for example:
(1) (1-Butyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as
JWH-073)
(2) (4-Chloronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also
known as JWH-398)
(3) [1-(4-Chloropent-1-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone
(also known as 4-Chloro-AM-2201)
(4) (4-Ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also
known as JWH-210)
(5) [1-(5-Fluoropent-1-yl)-1H-indol-3-yl](4-methylnaphthalen-1-yl)
methanone (also known as MAM-2201)
(6) [1-(5-Fluoropent-1-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone
(also known as AM-2201)
(7) [1-(4-Fluoropent-1-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone
(also known as 4-Fluoro-AM-2201)
(8) [1-(5-Fluoropent-1-yl)-6-nitro-1H-indol-3-yl](naphthalen-1-yl)
methanone (also known as AM-1235)
(9) [1-(Heptan-2-yl)-2-methyl-1H-indol-3-yl](naphthalen-1-yl)
methanone (also known as JWH-011)
(10) (1-Heptyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as
JWH-020)
(11) (1-Hexyl-1H-indol-3-yl)(naphthalen-1-yl)methanone (also known as
JWH-019)
(12) (4-Methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone (also
known as JWH-081)
(1AA) N-(1-Adamantyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
(also known as FUB-APINACA or FUB-AKB48) and its fluoro
positional isomers in the phenyl ring
[S 233/2018 wef 01/05/2018]
(2B) N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-
1H-indazole-3-carboxamide (also known as MAB-CHMINACA or
ADB-CHMINACA)
[S 194/2017 wef 01/05/2017]
(2BA) N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide (also known as ADB-FUBINACA) and its
fluoro positional isomers in the phenyl ring
[S 233/2018 wef 01/05/2018]
(2C) N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-
indazole-3-carboxamide (also known as 5-Fluoro-ADB-PINACA) and
its fluoro positional isomers in the pentyl group
[S 200/2016 wef 01/05/2016]
(2D) N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide (also known as ADB-PINACA)
[S 200/2016 wef 01/05/2016]
(2DA) N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-
carboxamide (also known as ADBICA)
[S 233/2018 wef 01/05/2018]
(2E) N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-chloropentyl)-1H-
indazole-3-carboxamide (also known as 5-Chloro-AB-PINACA) and
its N-(1-amino-1-oxopentan-2-yl) and N-(1-amino-2-methyl-1-
oxobutan-2-yl) isomers and their respective chloro positional
isomers in the pentyl group
[S 233/2018 wef 01/05/2018]
(2F) N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide (also known as AB-CHMINACA) and its N-
(1-amino-1-oxopentan-2-yl) and N-(1-amino-2-methyl-1-oxobutan-2-
yl) isomers
[S 233/2018 wef 01/05/2018]
(2G) N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide (also known as AB-FUBINACA) and its N-
(2H) N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-
indazole-3-carboxamide (also known as 5-Fluoro-AB-PINACA) and
its N-(1-amino-1-oxopentan-2-yl) and N-(1-amino-2-methyl-1-
oxobutan-2-yl) isomers and their respective fluoro positional
isomers in the pentyl group
[S 233/2018 wef 01/05/2018]
(2I) N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide (also known as AB-PINACA) and its N-(1-amino-1-
oxopentan-2-yl) and N-(1-amino-2-methyl-1-oxobutan-2-yl) isomers
[S 233/2018 wef 01/05/2018]
(2IA) N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide (also known as PX-3 or APP-CHMINACA)
[S 233/2018 wef 01/05/2018]
(2J) N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-
indazole-3-carboxamide (also known as PX-2 or 5-Fluoro-APP-
PINACA) and its fluoro positional isomers in the pentyl group
[S 194/2017 wef 01/05/2017]
(2K) N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-
indole-3-carboxamide (also known as PX-1 or 5-Fluoro-APP-PICA)
and its fluoro positional isomers in the pentyl group
[S 194/2017 wef 01/05/2017]
(6D) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
(also known as 25B-NBOMe) and its bromo, dimethoxy and methoxy
positional isomers in the respective phenyl rings
[S 233/2018 wef 01/05/2018]
(6E) 2-N-[2-(4-Bromo-2,5-dimethoxyphenylethyl)aminomethyl]phenol
(also known as 25B-NBOH) and its bromo, dimethoxy and hydroxy
positional isomers in the respective phenyl rings
[S 233/2018 wef 01/05/2018]
(6F) [1-(5-Bromopent-1-yl)-1H-indazol-3-yl](naphthalen-1-yl)methanone
(also known as 5-Bromo-THJ-018) and its bromo positional isomers in
the pentyl group
[S 587/2018 wef 01/10/2018]
(7) 17-Carboxy-16,17-dihydromitragynine
(8) 16-Carboxymitragynine
(8A) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine also known as 2C-C)
and its chloro and dimethoxy positional isomers in the phenyl ring
[S 233/2018 wef 01/05/2018]
(8AA) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
(also known as 25C-NBOMe) and its chloro, dimethoxy and methoxy
positional isomers in the respective phenyl rings
[S 233/2018 wef 01/05/2018]
(8AB) 2-N-[2-(4-Chloro-2,5-dimethoxyphenylethyl)aminomethyl]phenol
(also known as 25C-NBOH) and its chloro, dimethoxy and hydroxy
positional isomers in the respective phenyl rings
[S 233/2018 wef 01/05/2018]
(8AC) [1-(5-Chloropent-1-yl)-1H-indazol-3-yl](naphthalen-1-yl)methanone
(also known as 5-Chloro-THJ-018) and its chloro positional isomers in
the pentyl group
[S 587/2018 wef 01/10/2018]
(9) 17-O-Desmethyl-16,17-dihydromitragynine
(10) 9-O-Desmethylmitragynine
(10A) 3,4-Dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide
(also known as AH-7921) and its dichloro positional isomers in the
phenyl ring
[S 254/2015 wef 01/05/2015]
(10B) 3,4-Dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide
(also known as U-47700) and its dichloro positional isomers in the
phenyl ring and diamino positional isomers in the cyclohexyl ring
[S 194/2017 wef 01/05/2017]
(16) 6,6-Dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydro-6H-
benzo[c]chromen-1,9-diol
(17) N,N-Dimethyl-1-phenylpropan-2-amine (also known as N,N-
dimethylamphetamine)
(18) Diphenyl(pyrrolidin-2-yl)methanol (also known as diphenylprolinol)
(19A) Ethylphenidate
[S 200/2016 wef 01/05/2016]
(19ABA) 2-[1-(4-Fluorobenzyl)-1H-indazole-3-carboxamido]-3-
methylbutanoic acid and its 1-pentanoic acid and 2-methylbutanoic
acid isomers and their respective fluoro positional isomers in the
phenyl ring
[S 587/2018 wef 01/10/2018]
(19B) [1-(5-Fluoropent-1-yl)-1H-benzimidazol-2-yl](naphthalen-1-yl)
methanone (also known as FUBIMINA) and its fluoro positional
isomers in the pentyl group
[S 200/2016 wef 01/05/2016]
(19C) [1-(5-Fluoropent-1-yl)-1H-indazol-3-yl](naphthalen-1-yl)methanone
(also known as THJ-2201) and its fluoro positional isomers in the
pentyl group
[S 200/2016 wef 01/05/2016]
(20) [1-(5-Fluoropent-1-yl)-1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone (also known as XLR-11 or 5-
Fluoro-UR-144) and its fluoro positional isomers in the pentyl group
[S 254/2015 wef 01/05/2015]
(20C) 2-[1-(5-Fluoropentyl)-1H-indole-3-carboxamido]-3,3-
dimethylbutanoic acid and its hexanoic acid isomers and their
respective fluoro positional isomers in the pentyl group
[S 233/2018 wef 01/05/2018]
(23) 1-Hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6,6a,7,8,10,10a-
hexahydro-9H-benzo[c]chromen-9-one
(24) [9-Hydroxy-6-methyl-3-(5-phenylpentan-2-yl)oxy-
5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl]acetate
(25) 3-Hydroxy-2-[3-methyl-6-(2-propenyl)-cyclohex-2-en-1-yl]-5-
pentyl-1,4-benzoquinone
(26) 9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-
6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol (for example HU-
210, HU-211)
[S 194/2017 wef 01/05/2017]
(27) 7-Hydroxymitragynine
(27AA) [1-(5-Hydroxypent-1-yl)-1H-indazol-3-yl](naphthalen-1-yl)
methanone and its hydroxy positional isomers in the pentyl group
[S 587/2018 wef 01/10/2018]
(27B) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
(also known as 25I-NBOMe) and its dimethoxy, iodo and methoxy
positional isomers in the respective phenyl rings
[S 233/2018 wef 01/05/2018]
(27DA) [1-(5-Iodopent-1-yl)-1H-indazol-3-yl](naphthalen-1-yl)methanone
(also known as 5-Iodo-THJ-018) and its iodo positional isomers in the
pentyl group
[S 587/2018 wef 01/10/2018]
(31A) N-(1-Methyl-1-phenylethyl)-1-(4-cyanobutyl)-1H-indazole-3-
carboxamide (also known as Cumyl-4CN-BINACA or 4-Cyano
cumyl-butinaca or SGT-78) and its phenylpropyl isomers and their
respective cyano positional isomers in the butyl group
[S 233/2018 wef 01/05/2018]
(39) Salvinorin A
[S 323/2014 wef 01/05/2014]
19. Any compound (other than serotonin) structurally derived from 2-(1H-
indol-3-yl)ethanamine (also known as tryptamine) by modification in any of the
following ways:
(a) substitution at the nitrogen atom of the side chain to any extent with
alkyl or alkenyl substituents, or by inclusion of only the nitrogen atom
of the side chain in a cyclic structure;
(b) substitution at the carbon atom adjacent to the nitrogen atom of the side
chain with alkyl or alkenyl substituents;
(c) substitution in the 6-membered ring to any extent with alkyl, alkoxy,
haloalkyl, hydroxy, thioalkyl, alkylenedioxy, halide or acetoxy
substituents;
(d) substitution at the 2-position of the tryptamine ring system with an
alkyl substituent,
including any ether, salt or stereoisomeric form of any such compound, any
preparation or product containing any such compound, and the following
examples of such a compound:
(1) 4-Acetoxy-N,N-diisopropyltryptamine (also known as 4-Acetoxy-
DiPT or 4-AcO-DiPT)
(2) 4-Acetoxy-N,N-dimethyltryptamine (also known as 4-Acetoxy-DMT
or 4-AcO-DMT)
(3) 5-Benzyloxytryptamine
(4) 5-Bromo-N,N-dimethyltryptamine (also known as 5-Bromo-DMT)
(5) 5-Bromotryptamine
(6) 5-Chloro-α-methyltryptamine (also known as 5-Chloro-AMT)
PART II
CLASS B DRUGS
1. The following substances and products:
Acetyldihydrocodeine. Nicodicodine.
Codeine. Norcodeine.
Dextropropoxyphene. Phencyclidine.
Dihydrocodeine. Phenmetrazine.
Ethylmorphine (3-ethylmorphine). Pholcodine.
Fenetylline. Propiram.
Methylphenidate. Zipeprol.
Nicocodine.
PART III
CLASS C DRUGS
1. The following substances:
Benzphetamine. Methaqualone.
Chlorphentermine. Nimetazepam.
Flunitrazepam. Phendimetrazine.
Mecloqualone. Pipradrol.
Mephentermine. Secobarbital.
Triazolam.
PART IV
MEANING OF CERTAIN TERMS USED IN THIS SCHEDULE
For the purposes of this Schedule —
“cannabinol derivatives” means the following substances, namely tetrahydro
derivatives of cannabinol and their carboxylic acid derivatives, and 3-
alkyl homologues of cannabinol or its tetrahydro derivatives;
“coca leaf” means the leaf of any plant of the genus Erythroxylon from whose
leaves cocaine can be extracted either directly or by chemical
transformation;
Section
creating General nature of offence Punishment
offence
Specified drug or
CAP. 185
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
than 20 grammes of
morphine
Minimum 20 years —
and 15 strokes
(b) more than 1,200 — — — Death —
grammes and
Misuse of Drugs
being —
90
SECOND SCHEDULE — continued
91
Section
creating General nature of offence Punishment
offence
Specified drug or
CAP. 185
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
Minimum 20 years —
and 15 strokes
(b) more than 15 — — — Death —
grammes
(5) Unauthorised traffic in
controlled drug containing
Misuse of Drugs
Minimum 20 years —
and 15 strokes
92
SECOND SCHEDULE — continued
93
Section
creating General nature of offence Punishment
offence
Specified drug or
CAP. 185
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
(7) Unauthorised traffic in
cannabis mixture where the
quantity is —
(a) not less than 660 — — — Maximum 30 years —
grammes and not or imprisonment for
more than 1,000 life and 15 strokes
Misuse of Drugs
grammes
Minimum 20 years —
and 15 strokes
(b) more than 1,000 — — — Death —
grammes
(8) Unauthorised traffic in
Section
creating General nature of offence Punishment
offence
Specified drug or
CAP. 185
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
Minimum 20 years —
and 15 strokes
(b) more than 250 — — — Death —
grammes
6 (1) Unauthorised manufacture Maximum 30 Maximum 30 Maximum 20 — —
of controlled drug except as years or years or years and 15
Misuse of Drugs
Section
creating General nature of offence Punishment
offence
Specified drug or
CAP. 185
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
Minimum Minimum Minimum — —
5 years and 5 5 years and 5 3 years and 5
strokes strokes strokes
(2) Unauthorised import or
export of opium where the
quantity is —
Misuse of Drugs
Minimum 20 years —
and 15 strokes
98
SECOND SCHEDULE — continued
99
Section
creating General nature of offence Punishment
offence
Specified drug or
CAP. 185
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
(b) more than 30 — — — Death —
grammes
(4) Unauthorised import or
export of controlled drug
containing such quantity of
diamorphine being —
Misuse of Drugs
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
CAP. 185
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
(5) Unauthorised import or
export of controlled drug
containing such quantity of
cocaine being —
(a) not less than 20 — — — Maximum 30 years —
grammes and not or imprisonment for
Misuse of Drugs
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
(a) not less than 330 — — — Maximum 30 years —
grammes and not or imprisonment for
more than 500 life and 15 strokes
grammes
Minimum 20 years —
and 15 strokes
Misuse of Drugs
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
CAP. 185
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
Minimum 20 years —
and 15 strokes
(b) more than 1,000 — — — Death —
grammes
(8) Unauthorised import or
export of cannabis resin
Misuse of Drugs
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
(9) Unauthorised import or
export of controlled drug
containing such quantity of
methamphetamine being —
(a) not less than 167 — — — Maximum 30 years —
grammes and not or imprisonment for
Misuse of Drugs
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
CAP. 185
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
Minimum for
second or
subsequent
offence 2
years
8 (b) Smoking, self-administering or — — — — Maximum 10
Misuse of Drugs
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
$40,000 or
both
Minimum 3
years or
$5,000 or
both
Misuse of Drugs
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
CAP. 185
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
Minimum 2 Minimum 2 Minimum 12 — —
years or years or months or
$4,000 or both $4,000 or both $2,000 or
both
12A Causing or procuring young Maximum Maximum Maximum — —
person or vulnerable person to 30 years and 30 years and 20 years and
Misuse of Drugs
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
$4,000 or
both
30(1)(a) Obstructing exercise of powers — — — — Maximum 3
years or
$5,000 or
both
Misuse of Drugs
Minimum 6
months or
$1,000 or
both
30(1)(b) Failure to comply with lawful — — — — Maximum 3
requirements years or
both
Minimum 6
months or
108
SECOND SCHEDULE — continued
109
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
CAP. 185
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
$1,000 or
both
30(1)(c) Failure to furnish information — — — — Maximum 3
years or
$5,000 or
both
Misuse of Drugs
Minimum 6
months or
$1,000 or
both
30(1)(d) Furnishing false information — — — — Maximum 12
months or
Section
creating General nature of offence Punishment
offence
Specified drug or
Class A Class B Class C
quantity thereof or
drug drug drug General
drug with specified
involved involved involved
content involved
$20,000 or
both
31A(2) Failure to provide specimens of — — — — Maximum 2
hair for hair testing years or
$5,000 or
both
Misuse of Drugs
PART II
1. The following substances:
Acetone also known as 2-Propanone or Dimethyl ketone
Anthranilic acid also known as o-Aminobenzoic acid
Ethyl ether also known as Ether or Diethyl ether or Ethyl oxide or Diethyl
oxide or Ethoxyethane or 1,1’-Oxybisethane
Hydrochloric acid
Methyl ethyl ketone also known as 2-Butanone
Piperidine also known as Hexahydropyridine
Sulphuric acid
Toluene also known as Methylbenzene or Phenylmethane.
FOURTH SCHEDULE
Sections 2 and 33A
SPECIFIED DRUGS
1. Amphetamine
2. N,α-Dimethyl-3,4-(methylenedioxy)phenethylamine (also known as
MDMA)
[S 323/2014 wef 01/05/2014]
2A. Buprenorphine
2B. Cannabinol
5. Ketamine
6. Methamphetamine (also known as Methylamphetamine)
7. α-Methyl-3,4-(methylenedioxy)phenethylamine (also known as
Tenamfetamine or MDA)
[S 323/2014 wef 01/05/2014]
8. Monoacetylmorphine
9. Morphine
10. Nimetazepam
10A. Norbuprenorphine
11. Norketamine and its dehydro derivatives
12. Opium.
[2/2006; S 560/2006; S 402/2007]
FIFTH SCHEDULE
Sections 24, 26, 27, 32 and 58A